Preparation and characterizations of antibiotic impregnated microporous nano-hydroxyapatite for osteomyelitis treatment

Biomedical Engineering - Applications, Basis and Communications

Volumn 26, Issue 3, 2014, Pages

  Suwanprateeb, J ^a   Thammarakcharoen, F ^a   Phanphiriya, P ^a   Chokevivat, W ^a   Suvannapruk, W ^a   Chernchujit, B ^b  

^a NATIONAL METAL AND MATERIALS TECHNOLOGY CENTER   (Thailand)

^b THAMMASAT UNIVERSITY   (Thailand)

Author keywords

Bone infection; Drug release; Phase transformation; Three dimensional printing

Indexed keywords

BONE; EXTRACTION; HYDROXYAPATITE; LOADING; MATERIALS PROPERTIES; MICROPOROSITY; NANOCOMPOSITES; PHASE TRANSITIONS;

ANTI-BACTERIAL ACTIVITY; ANTI-BACTERIAL PERFORMANCE; BONE INFECTION; DRUG RELEASE; HIGH-TEMPERATURE SINTERING; MECHANISM OF ACTION; NANO-HYDROXYAPATITE; THREE-DIMENSIONAL PRINTING;

ANTIBIOTICS;

CALCIUM SULFATE; FOSFOMYCIN; FOSFOMYCIN SODIUM; GENTAMICIN; HYDROXYAPATITE; NANOPARTICLE; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; ESCHERICHIA COLI; HIGH TEMPERATURE; HUMAN; HUMAN CELL; KLEBSIELLA PNEUMONIAE; LOW TEMPERATURE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR WEIGHT; NONHUMAN; OSTEOMYELITIS; PARTICLE SIZE; PSEUDOMONAS AERUGINOSA; SHELF LIFE; STAPHYLOCOCCUS AUREUS; SUSTAINED DRUG RELEASE;

EID: 85027942615     PISSN: 10162372     EISSN: None     Source Type: Journal    
DOI: 10.4015/S1016237214500410     Document Type: Article

References (27)

1. Carek PJ, Dickerson LM, Sack JL, Diagnosis and management of osteomyelitis, Am Fam Physician 63:2413, 2001.
2. Lew DP, Waldvogel FA, Osteomyelitis, Lancet 364:369, 2004.
3. Mader JT, Ortiz M, Calhoun JH, Update on the diagnosis and management of osteomyelitis, Clin Pediatr Med Surg 13:701, 1996.
4. Nandi SK, Mukherjee P, Roy S, Kundu B, De DK, Basu D, Local antibiotic delivery systems for the treatment of osteomyelitis-A review, Mater Sci Eng C 29:2478, 2009.
5. Zalavras CG, Patzakis MJ, Holtom P, Local antibiotic therapy in the treatment of open fractures and osteomyelitis, Clin Orthop Relat Res 427:86, 2004.
6. Diefenbeck M, MUckley T, Hofmann GO, Prophylaxis and treatment of implanted related infections by local application of antibiotics, Injury 37:S95, 2006.
7. Davenport K, Traina S, Perry C, Treatment of acutely infected arthroplasty with local antibiotics, J Arthroplasty 6:179, 1991.
8. Wininger DA, Fass RJ, Antibiotic-impregnated cement and beads for orthopedic infections, Antimicrob Agents Chemother 40:2675, 1996.
9. Gogia JS, Meehan JP, Di Cesare PE, Jamali AA, Local antibiotic therapy in osteomyelitis, Semin Plast Surg 23:100, 2009.
10. Shinto Y, Uchida A, Korkusuz F, Araki N, Ono K, Calcium hydroxyapatite ceramic used as a delivery system for antibiotics, J Bone Joint Surg 74B:600, 1992.
11. Yamashita Y, Uchida A, Yamakawa T, Shinto Y, Araki N, Kato K, Treatment of chronic osteomyelitis using calcium hydroxyapatite ceramic implants impregnated with antibiotic, Int Orthop 22:247, 1998.
12. Sl-osarczyk A, Szymura-Oleksiak J, Mycek B, The kinetics of pentoxifylline release from drug-loaded hydroxyapatite implants, Biomaterials 21:1215, 2000.
13. Chotanaphuti T, Surijamorn P, Luenam S, Ongnamthip P, In vitro antimicrobial activity of phramongkutklao hydroxyapatite antibiotic pellet, J Med Assoc Thai 91:1868, 2008.
14. Chai F, Hornez JC, Blanchemain N, Neut C, Descamps M, Hildebrand HF, Antibacterial activation of hydroxyapatite (HA) with controlled porosity by di erent antibiotics, Biomol Eng 24:510, 2007.
15. Suwanprateeb J, Suvannapruk W, Wasoontararat K, Low temperature preparation of calcium phosphate structure via phosphorization of 3D-printed calcium sulfate hemihydrate based material, J Mater Sci Mater Med 21:419, 2010.
16. Suwanprateeb J, Thammarakcharoen F, Wasoontararat K, Suvannapruk W, Inuence of printing parameters on the transformation eciency of 3D-printed plaster of paris to hydroxyapatite and its properties, Rapid Prototyping J 18:490, 2012.
17. Chung Ren-Jei, Study of hydroxyapatite nano composites with photoluminescence properties, Biomed Eng Appl Basis Commun 23:107, 2011.
18. Peters F, Schwarz K, Epple M, The structure of bone studied with synchrotron X-ray di raction, X-ray absorption spectroscopy and thermal analysis, Thermochim Acta 361:131, 2000.
19. Kim HW, Lee EJ, Jun IK, Kim HE, Knowles JC, Degradation and drug release of phosphate glass/polycaprolactone biological composites for hard-Tissue regeneration, J Biomed Mater Res B Appl Biomater 75B:34, 2005.
20. Wang Q, Wang Q, Wang J, Zhang X, Yu X, Wan C, Degradation kinetics of calcium polyphosphate bioceramic: An experimental and theoretical study, Mater Res 12:495, 2009.
21. Alvarez S, Jones M, Berk SL, In vitro activity of fosfomycin, alone and in combination, against methicillinresistant Staphylococcus aureus, Antimicrob Agents Chemother 28:689, 1985.
22. Graninger W, Leitha T, Georgopoulos A, Havel M, In vitro activity of fosfomycin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus, Infection 12:293, 1984.
23. Antoci V Jr, Adams CS, Hickok NJ, Shapiro IM, Parvizi J, Antibiotics for local delivery systems cause skeletal cell toxicity in vitro, Clin Orthop Relat Res 462:200, 2007.
24. Rathbone CR, Cross JD, Brown KV, Murray CK, Wenke JC, E ect of various concentrations of antibiotics on osteogenic cell viability and activity, J Orthop Res 29:1070, 2011.
25. Pountos I, Georgouli T, Bird H, Kontakis G, Giannoudis PV, The e ect of antibiotics on bone healing: Current evidence, Expert Opin Drug Saf 10:935, 2011.
26. Clark GS, Shelf Life of Medical Devices, Center for Devices and Radiological Health, FDA, Maryland, 1991.
27. Gbureck U, Dembski S, Thull R, Barralet JE, Factors inuencing calcium phosphate cement shelf-life, Biomaterials 26:3691, 2005.